ADVITOS receives EIC Accelerator funding to enhance therapy options for Corona Patients with severe organ dysfunction
30.06.2020 Munich – ADVITOS, which received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 880349, is one of